CSE: IN OTCQB: IMLFF
VANCOUVER, March 13, 2018 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today the…
